Ahead of the Bell: Merck price target cut after FDA denial
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Ahead of the Bell: Merck price target cut after FDA denial
29 Apr 08, 11:43
NEW YORK (AP) - An analyst cut a price target on Merck & Co. Tuesday, the day after the Food & Drug Administration rejected an experimental drug that would ...
more

 

 
© 2007 nafdacnigeria.org